PTC Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoma+4 more
AstraZeneca161 enrolled33 locationsNCT06137144
Recruiting
Phase 1
To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL
CD7 Positive R/R PTCL
Peking University People's Hospital18 enrolled1 locationNCT07143929